Kestra Medical Technologies appoints Curtis Kopf as SVP of Customer Experience to enhance patient support and technology integration.
Quiver AI Summary
Kestra Medical Technologies, Ltd. has appointed Curtis Kopf as Senior Vice President of Customer Experience, a newly created position aimed at enhancing the patient journey with the ASSURE® WCD device. Kopf will oversee all aspects of patient interaction from order approval to therapy completion, focusing on aligning people, processes, and technology to ensure support for both providers and patients. CEO Brian Webster emphasized that Kestra's mission is to deliver innovative medical technologies that foster patient engagement and confidence throughout their care. Kopf, who brings significant experience from roles at Insulet Corporation and REI, aims to strengthen patient support and simplify the user experience while maintaining essential personal connections. This appointment coincides with Kestra's investment in commercial capabilities and artificial intelligence initiatives to drive growth and improve patient outcomes in cardiovascular care.
Potential Positives
- The appointment of Curtis Kopf as Senior Vice President of Customer Experience strengthens Kestra's commitment to enhancing patient support and engagement throughout therapy.
- Mr. Kopf's extensive experience in customer experience and digital transformation positions the company to advance its operational efficiency and patient care strategies.
- Kestra's investments in artificial intelligence initiatives alongside this appointment indicate a focus on leveraging technology to improve service delivery and patient experience.
Potential Negatives
- The creation of a new Senior Vice President position may indicate previous deficiencies in customer experience management that needed addressing.
- Mr. Kopf's limited prior experience in the medical technology sector could raise concerns about his ability to navigate the unique challenges of the industry.
FAQ
Who is Curtis Kopf and what is his new role at Kestra Medical Technologies?
Curtis Kopf is appointed as Senior Vice President of Customer Experience, leading patient experience throughout therapy with the ASSURE® WCD.
What is the mission of Kestra Medical Technologies?
Kestra's mission is to provide innovative medical technologies that protect and support at-risk patients during their care journey.
How will Curtis Kopf improve patient experience at Kestra?
He aims to simplify the patient journey and strengthen support through data and automation, enhancing engagement and confidence in therapy.
What initiatives is Kestra Medical pursuing to enhance its capabilities?
Kestra is investing in artificial intelligence initiatives to improve customer-facing operations and drive growth in its commercial capabilities.
Where can I find more information about Kestra Medical Technologies?
You can find more information about Kestra Medical Technologies on their official website at www.kestramedical.com.
Disclaimer: This is an AI-generated summary of a press release distributed by GlobeNewswire. The model used to summarize this release may make mistakes. See the full release here.
$KMTS Insider Trading Activity
$KMTS insiders have traded $KMTS stock on the open market 34 times in the past 6 months. Of those trades, 1 have been purchases and 33 have been sales.
Here’s a breakdown of recent trading of $KMTS stock by insiders over the last 6 months:
- BRIAN DANIEL WEBSTER (See Remarks) has made 0 purchases and 15 sales selling 171,722 shares for an estimated $3,944,857.
- VASEEM MAHBOOB (Chief Financial Officer) has made 0 purchases and 7 sales selling 51,470 shares for an estimated $1,271,234.
- ALFRED J JR FORD (Chief Commercial Officer) has made 0 purchases and 4 sales selling 33,907 shares for an estimated $793,664.
- TRACI S UMBERGER (See Remarks) has made 0 purchases and 4 sales selling 25,809 shares for an estimated $598,864.
- TIMOTHY P. MORAN (Chief Business Officer) has made 0 purchases and 3 sales selling 15,256 shares for an estimated $348,310.
- RAYMOND W COHEN purchased 10,000 shares for an estimated $199,800
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.
$KMTS Revenue
$KMTS had revenues of $28.6M in Q4 2026. This is an increase of 66.18% from the same period in the prior year.
You can track KMTS financials on Quiver Quantitative's KMTS stock page.
You can access data on KMTS stock through the Quiver Quantitative API.
$KMTS Hedge Fund Activity
We have seen 71 institutional investors add shares of $KMTS stock to their portfolio, and 46 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- PRICE T ROWE ASSOCIATES INC /MD/ removed 999,764 shares (-16.8%) from their portfolio in Q2 2026, for an estimated $25,433,996
- POINT72 ASSET MANAGEMENT, L.P. added 526,626 shares (+inf%) to their portfolio in Q2 2026, for an estimated $13,397,365
- PERCEPTIVE ADVISORS LLC removed 285,000 shares (-100.0%) from their portfolio in Q1 2026, for an estimated $5,680,050
- JENNISON ASSOCIATES LLC removed 219,355 shares (-100.0%) from their portfolio in Q1 2026, for an estimated $4,371,745
- FMR LLC removed 197,407 shares (-3.5%) from their portfolio in Q2 2026, for an estimated $5,022,034
- LORD, ABBETT & CO. LLC removed 192,622 shares (-100.0%) from their portfolio in Q1 2026, for an estimated $3,838,956
- BROWN ADVISORY INC added 185,326 shares (+10.8%) to their portfolio in Q2 2026, for an estimated $4,714,693
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
$KMTS Analyst Ratings
Wall Street analysts have issued reports on $KMTS in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- BTIG issued a "Buy" rating on 03/25/2026
To track analyst ratings and price targets for $KMTS, check out Quiver Quantitative's $KMTS forecast page.
$KMTS Price Targets
Multiple analysts have issued price targets for $KMTS recently. We have seen 2 analysts offer price targets for $KMTS in the last 6 months, with a median target of $24.5.
Here are some recent targets:
- David Roman from Goldman Sachs set a target price of $17.0 on 04/09/2026
- Marie Thibault from BTIG set a target price of $32.0 on 04/07/2026
Full Release
KIRKLAND, Wash., Aug. 26, 2026 (GLOBE NEWSWIRE) -- Kestra Medical Technologies, Ltd. (Nasdaq: KMTS), a leading wearable medical device and digital healthcare company, today announced the appointment of Curtis Kopf as Senior Vice President of Customer Experience. In this newly created role, Mr. Kopf will lead the patient experience from approval of a patient order through completion of therapy and device return, aligning the people, processes and technology that support providers and their patients throughout the use of the ASSURE ® WCD.
“Our mission is to provide innovative, intuitive medical technologies to protect and support at-risk patients. That mission guides both the technology we create and the experience we deliver, helping patients begin therapy with confidence and remain engaged, connected, and protected throughout their care,” said Brian Webster, President and Chief Executive Officer. “Curtis brings the vision and experience to lead that journey end to end, harnessing data and automation to scale patient support, strengthen performance at every stage, and extend the impact of the ASSURE WCD and the broader Cardiac Recovery System platform to more patients.”
Mr. Kopf has extensive experience leading customer experience, digital transformation, and large-scale service operations. Most recently, he served as Group Vice President, Global Customer Experience at Insulet Corporation, where he led a global organization of more than 1,000 employees across digital, customer service, and customer success and helped advance the adoption of artificial intelligence across a large-scale service organization. Previously, he served as Chief Experience Officer and Chief Digital Officer at REI, where he led customer experience, digital, analytics, innovation, and service organizations.
“Every interaction is an opportunity to build confidence, remove friction, and help patients stay connected throughout their cardiac recovery,” said Mr. Kopf. “Kestra has built a powerful combination of differentiated technology and deeply committed patient support. I look forward to working with the team to anticipate patient needs, simplify each step of the journey, and scale that experience while preserving the human connection that matters most.”
The appointment of Mr. Kopf comes as Kestra invests in its commercial capabilities, including multiple artificial intelligence initiatives designed to drive operating leverage across its customer-facing operations. These investments are expected to position Kestra for its next stage of growth by advancing the technology that protects patients and the experience that supports them.
About Kestra
Kestra Medical Technologies, Ltd. is a commercial-stage wearable medical device and digital healthcare company focused on transforming patient outcomes in cardiovascular disease using monitoring and therapeutic intervention technologies that are intuitive, intelligent, and connected. For more information, please visit
www.kestramedical.com
.
